These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 6298169

  • 1. Cefoxitin, N-formimidoyl thienamycin, clavulanic acid, and penicillanic acid sulfone as suicide inhibitors for different types of beta-lactamases produced by gram-negative bacteria.
    Sawai T, Tsukamoto K.
    J Antibiot (Tokyo); 1982 Nov; 35(11):1594-602. PubMed ID: 6298169
    [Abstract] [Full Text] [Related]

  • 2. Induction/inhibition of chromosomal beta-lactamases by beta-lactamase inhibitors.
    Moosdeen F, Keeble J, Williams JD.
    Rev Infect Dis; 1986 Nov; 8 Suppl 5():S562-8. PubMed ID: 3026004
    [Abstract] [Full Text] [Related]

  • 3. Sulbactam: biochemical factors involved in its synergy with ampicillin.
    Labia R, Morand A, Lelievre V, Mattioni D, Kazmierczak A.
    Rev Infect Dis; 1986 Nov; 8 Suppl 5():S496-502. PubMed ID: 3025996
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In-vitro evaluation of the four beta-lactamase inhibitors: BRL42715, clavulanic acid, sulbactam, and tazobactam.
    Muratani T, Yokota E, Nakane T, Inoue E, Mitsuhashi S.
    J Antimicrob Chemother; 1993 Sep; 32(3):421-9. PubMed ID: 8262864
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Penicillanic acid sulfone: nature of irreversible inactivation of RTEM beta-lactamase from Escherichia coli.
    Brenner DG, Knowles JR.
    Biochemistry; 1984 Nov 20; 23(24):5833-9. PubMed ID: 6098299
    [Abstract] [Full Text] [Related]

  • 9. Kinetic studies on inactivation of Citrobacter freundii cephalosporinase by sulbactam.
    Yamaguchi A, Hirata T, Sawai T.
    Antimicrob Agents Chemother; 1983 Jul 20; 24(1):23-30. PubMed ID: 6312873
    [Abstract] [Full Text] [Related]

  • 10. Beta-lactamase inhibitors: relation between kinetic data and in-vitro synergism studies.
    Cullmann W.
    Zentralbl Bakteriol; 1991 Oct 20; 275(4):500-3. PubMed ID: 1661596
    [Abstract] [Full Text] [Related]

  • 11. Amino acid sequence, active-site residue, and effect of suicide inhibitors on cephalosporinase of Citrobacter freundii GN346.
    Sawai T, Yamaguchi A, Tsukamoto K.
    Rev Infect Dis; 1988 Oct 20; 10(4):721-5. PubMed ID: 3263684
    [Abstract] [Full Text] [Related]

  • 12. Effects of azlocillin in combination with clavulanic acid, sulbactam, and N-formimidoyl thienamycin against beta-lactamase-producing, carbenicillin-resistant Pseudomonas aeruginosa.
    Calderwood SB, Gardella A, Philippon AM, Jacoby GA, Moellering RC.
    Antimicrob Agents Chemother; 1982 Aug 20; 22(2):266-71. PubMed ID: 6100423
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of beta-lactamases by tazobactam and in-vitro antibacterial activity of tazobactam combined with piperacillin.
    Higashitani F, Hyodo A, Ishida N, Inoue M, Mitsuhashi S.
    J Antimicrob Chemother; 1990 Apr 20; 25(4):567-74. PubMed ID: 2161820
    [Abstract] [Full Text] [Related]

  • 14. Novel carbapenem derivative SF2103A: studies on the mode of beta-lactamase inactivation.
    Yamaguchi A, Hirata T, Sawai T.
    Antimicrob Agents Chemother; 1984 Mar 20; 25(3):348-53. PubMed ID: 6372682
    [Abstract] [Full Text] [Related]

  • 15. Activity of 13 beta-lactam agents combined with BRL 42715 against beta-lactamase producing gram-negative bacteria compared to combinations with clavulanic acid, tazobactam and sulbactam.
    Piddock LJ, Jin YF, Turner HL.
    J Antimicrob Chemother; 1993 Jan 20; 31(1):89-103. PubMed ID: 8383105
    [Abstract] [Full Text] [Related]

  • 16. Characteristics of aztreonam as a substrate, inhibitor and inducer for beta-lactamases.
    Sakurai Y, Yoshida Y, Saitoh K, Nemoto M, Yamaguchi A, Sawai T.
    J Antibiot (Tokyo); 1990 Apr 20; 43(4):403-10. PubMed ID: 2112533
    [Abstract] [Full Text] [Related]

  • 17. 6-(Methoxymethylene)penicillanic acid: inactivator of RTEM beta-lactamase from Escherichia coli.
    Brenner DG, Knowles JR.
    Biochemistry; 1984 Nov 20; 23(24):5839-46. PubMed ID: 6098300
    [Abstract] [Full Text] [Related]

  • 18. [Sulbactam and clavulanic acid: studies of enzyme kinetics and synergism with ampicillin and mezlocillin].
    Cullmann W, Binder S, Stieglitz M.
    Immun Infekt; 1987 May 20; 15(3):103-9. PubMed ID: 3038733
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Interaction of clavulanic acid, sulbactam and cephamycin antibiotics with beta-lactamases.
    Grace ME, Fu KP, Gregory FJ, Hung PP.
    Drugs Exp Clin Res; 1987 May 20; 13(3):145-8. PubMed ID: 3040368
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.